This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

RANDY ROCKNEY, MD
Department of Pediatrics Brown University Program in Medicine Memorial Hospital of Rhode Island Pawtucket, RI 02860

Am J Dis Child. 1988;142(9):913.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Sir.—In his editorial on the use of ribavirin to treat respiratory syncytial virus (RSV) infections, published in the May 1988 issue of the AJDC, Ray¹ poses a number of unresolved questions and invites readers to add to his list. While there is a well-known association between RSV infections and apnea, especially in young infants or those with a history of prematurity,² it is not known if treatment with ribavirin is either warranted or effective in infants in whom apnea is the major, and sometimes the only, manifestation of infection.

Patient Reports.—PATIENT 1.—A 25-day-old full-term male infant who was normal at birth, except for a hemodynamically insignificant ventricular septal defect, was admitted after having had a prolonged apneic episode accompanied by profound cyanosis while at home. The infant had had two to three days of mild nasal congestion before this episode. The infant responded to bag-and-mask . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?